4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Innate Inflammatory Response in 2 studies
WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, YB | 1 |
| Ahn, M | 1 |
| Lee, SM | 1 |
| Koh, HW | 1 |
| Lee, SH | 1 |
| Kim, SH | 1 |
| Park, BH | 1 |
| Kim, HJ | 1 |
| Hart, J | 1 |
| Knatz, N | 1 |
| Hall, MW | 1 |
| Wewers, MD | 1 |
2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Innate Inflammatory Response
| Article | Year |
|---|---|
Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice.
Topics: Animals; Apoptosis; Cell Movement; Chemokines; Heart Function Tests; Inflammation; Janus Kinase 3; M | 2013 |
Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10.
Topics: Animals; Autocrine Communication; Caspase 1; Caspase Inhibitors; Cells, Cultured; Down-Regulation; E | 2004 |